The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies

Human Pathology

Volumn 32, Issue 2, 2001, Pages 205-215

  Meehan, S M ^a   Domer, P ^a   Josephson, M ^a   Donoghue, M ^a   Sadhu, A ^a   Ho, L T ^a   Aronson, A J ^a   Thistlethwaite, J R ^a   Haas, M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acute rejection; Allograft; Kidney; Plasma cells; Posttransplantation lymphoproliferative disease

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; FEMALE; GENE REARRANGEMENT; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; KIDNEY BIOPSY; KIDNEY GRAFT; LYMPHOPROLIFERATIVE DISEASE; MALE; PLASMACYTOSIS; PROGNOSIS; SURVIVAL TIME;

EID: 0035127487     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.21574     Document Type: Article

References (38)

1. Renal transplant pathology
2. Interstitial mononuclear cell populations in renal allograft rejection
3. Immunopathology of renal allograft rejection analysed with monoclonal antibodies to mononuclear cell markers
4. Analysis of intragraft effector mechanisms associated with human renal allograft rejection: Immunohistological studies with monoclonal antibodies
5. Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system
6. Pathology of kidney transplantation
7. T and B cell patterns in irreversibly rejected human renal allografts
8. Importance of plasma cells in the infiltrate of renal allografts. An immunohistochemical study
9. Acute interstitial nephritis of plasma cells: A new cause for renal allograft loss
10. Plasma cell rich acute renal allograft rejection
11. The Banff 97 working classification of renal allograft pathology
12. Immunophenotypic criteria for the diagnosis of non-Hodgkins lymphoma
13. Allergic interstitial nephritis: Report of a case with activation of complement by the alternate pathway
14. Drug induced acute interstitial nephritis with granulomas
15. Late acute renal allograft rejection and symptomless cytomegalovirus infection
16. Immunoglobulin secreting cells recovered from rejected human renal allografts
17. C4d deposits in peritubular capillaries in chronic renal allograft rejection
18. Peritubular capillary lamination: A marker of antibody mediated chronic rejection of renal allografts
19. Pathologic features of acute renal allograft rejection associated with donor-specific antibody
20. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
21. Lymphoproliferative disorders and hematologic malignancies following organ transplantation
22. Renal allograft involvement by Epstein-Barr virus associated posttransplantation lymphoproliferative disease
23. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression
24. Kidney allograft with a lymphocytic infiltrate: Acute rejection, posttransplantation lymphoproliferative disorder, neither or both entities?
25. Posttransplantation lymphoproliferative disorder in a renal allograft recipient
26. Posttransplant lymphoproliferative disorder in renal allograft recipients
27. Epstein-Barr virus associated lymphoproliferation arising in a renal allograft
28. Intragraft angiotropic large cell lymphoma of T cell type in a long term renal allograft recipient
29. Posttransplantation lymphoproliferative disorder of the NK-cell type: A case report and a review of the literature
30. Posttransplant lymphoproliferative disorders: Summary of Society for Hematopathology workshop
31. Epstein-Barr virus negative posttransplant lymphoproliferative disorders. A distinct entity?
32. Multiple myeloma following reactivated Epstein-Barr virus infection in a renal transplant recipient
33. Plasma cell lymphoma after renal transplantation
34. Extramedullary plasmacytoma of the gastrointestinal tract in a renal transplant recipient
35. Multiple myeloma in a renal transplant recipient
36. Multiple myeloma and AL amyloidosis in a renal transplant recipient
37. Occurrence of multiple myeloma three years after successful renal transplantation
38. Asecretory myeloma in a renal transplant recipient